RoACTEMRA: New hope for children with systemic Juvenile Idiopathic Arthritis - Insciences Organisation

RoACTEMRA: New hope for children with systemic Juvenile Idiopathic Arthritis Insciences Organisation Abstract presented on 18th June 2010 at EULAR ii) Woo, P. Systemic juvenile rheumatoid arthritis: diagnosis, management, and outcome. ... RoACTEMRA: New hope for children with systemic Juvenile Idiopathic ArthritisChem.Info all 11 news articles »

New hope for childhood arthritis - PharmiWeb.com (press release)

New hope for childhood arthritis PharmiWeb.com (press release) Accessed June 2010 5 Woo P. Systemic juvenile rheumatoid arthritis: diagnosis, management, and outcome. Nature Clinical Practice: Rheumatology. 2006. ... Drug 'could help JIA sufferers'The Press Association Drug "could aid juvenile arthritis"Nursing in Practice Drug boost in JIA study resultsPharmacy Europe all 8 news articles »

New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published by The Lancet ... - PR Newswire (press release)

New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published by The Lancet ... PR Newswire (press release) CELEBREX is currently approved in the US for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis in adults, juvenile rheumatoid ... and more »

EULAR: Novel Agent Eases Gout Pain - MedPage Today

EULAR: Novel Agent Eases Gout Pain MedPage Today The study, published online June 8 in Arthritis & Rheumatism, showed that treatment with the monoclonal antibody rapidly reduced pain caused by gouty ... and more »